China Pharmaceutical (CFMI) 0.0051 $CFMI
SciClone Reports Third Quarter 2015 Financial Results
PR Newswire - Mon Nov 09, 3:05PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015.
SCLN: 14.41 (+0.05)
Global Pharmaceuticals RFID Industry Forecast Report, Market Outlook 2014
M2 - Tue Oct 27, 4:38AM CDT
Product Synopsis
Market Analysis Of Global Pharmaceutical Industries And Trend Estimation Featuring Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline & Eli Lilly & Company
M2 - Mon Aug 17, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/22ql9d/market_analysis) has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering. The report analyzes the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies like Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company. The latest annual reports of all companies were analyzed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources. Key Topics Covered: 1. Pharmaceutical And Pharmaceutical Company 1.1 Pharmaceutical Company 1.2 Definition Of Medicinal Product Or Drug 1.3 Classification Of Drugs 1.4 History Of Drugs 1.5 Ancient Pharmacology 1.6 Medieval Pharmacology 1.7 Modern Pharmacology 1.8 Drugs And Intellectual Property Rights 2. Generic Industry 2.1 Generic Industry 2.2 Introduction To The Generic Market 2.3 Leading Companies In The Generic Industry 2.4 The Generic Industry And Mergers & Acquisitions 2.5 Generic Industry & Emerging Markets 2.6 Conclusion To The Generics Industry 3. Pharmaceutical Industries In Selected Countries Of The World 3.1 German Pharmaceutical Industry 3.2 Russian Pharmaceutical Market 3.3 Russian Pharma Company 3.4 Russian Pharmaceuticals Market 3.5 Us Pharmaceuticals Market 3.6 Australia Pharmaceuticals Industry 3.7 China Pharmaceuticals Industry 3.8 Indian Pharmaceuticals Industry 4. Financial Analysis Of Top Pharmaceutical Companies 4.1 Pfizer 4.2 Johnson & Johnson 4.3 Abbott Pharmaceuticals 4.4 Gilead 4.5 Sun Pharma 4.6 Glaxo Smith Kline Annual Report 4.7 Eli Lilly & Company Annual Report 5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation 5.1 Trends In The Pharmaceutical And Related Industries 5.2 Value Chains 5.3 Supply Chains 5.4 Process, Development & Design 5.5 Optimised Planning Of Tests 5.6 Capacity And Portfolio Planning Under Uncertainty 5.7 Combined Testing And Capacity Planning 5.8 Classical Supply Chain Planning And Management 5.9 Issues/Structure 5.10 Dynamic Supply Chain Analysis 5.11 A Particular Market 5.12 Comparison Of Two Supply Chain Responses 5.13 Some Conclusions 5.14 Future Perspectives 6. Management, Discussion And Analysis Report Of Global Pharma Industry 7. Summary For more information visit http://www.researchandmarkets.com/research/22...t_analysis
LLY: 73.64 (-0.22)
Pharmaceutical Directory of China 2015
M2 - Tue Jul 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wz73cd/pharmaceutical) has announced the addition of the "Pharmaceutical Directory of China 2015" directory to their offering. The Chinese pharmaceutical industry has increased with high annual average growth rates over the last few decades. And during 2014 this strong growth is expected to continue unabated. This new edition of the China Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to China's ever-changing pharmaceutical industry. If you need to source from, or sell to China, Pharmaceuticals, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you're looking to break into this appealing market, the new China Pharmaceutical Directory will provide you with thousands of fresh business contacts - and help you keep track of old ones - quickly and easily. This one directory covers the entire Chinese pharmaceutical & biotechnology industries sector. This Directory will enable you to: - Profile a market - Build new business prospects - Pinpoint key executives - Generate new customers - Discover who your competitors are - Make vital contacts - Save the time, money and effort of doing your own research - Identify alternative suppliers and manufacturers - Source up-to-date company information - Access a wealth of quality information on companies and key personnel. Look at the information you'll get in the China Pharmaceutical Directory: - Address - Telephone, fax numbers - Email, website - Names of senior management and board members - Senior executives - Description of business activities - Subsidiaries and associates - Number of employees For more information visit http://www.researchandmarkets.com/research/wz...maceutical
China Pharmaceuticals Markets Research And Forecast Report: Radiant Insights
M2 - Wed Jun 03, 11:42AM CDT
RadiantInsights.com has announced the addition of "China Pharmaceuticals Markets Trends, Growth And Forecast Report : Radiant Insights, Inc" Market Research Report to their Database.
China Pharmaceuticals Markets Growth, Trends
M2 - Tue Jun 02, 7:47AM CDT
China's demand for Pharmaceuticals (http://www.radiantinsights.com/research/pharmaceuticals-markets-in-china) has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.
China Pharmaceuticals and Healthcare Report Q1 2015
PR Newswire - Wed Dec 24, 7:30AM CST
BMI View:Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.
SciClone Reports Third Quarter 2015 Financial Results
PR Newswire - Mon Nov 09, 3:05PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015.
SCLN: 14.41 (+0.05)
Global Pharmaceuticals RFID Industry Forecast Report, Market Outlook 2014
M2 - Tue Oct 27, 4:38AM CDT
Product Synopsis
Market Analysis Of Global Pharmaceutical Industries And Trend Estimation Featuring Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline & Eli Lilly & Company
M2 - Mon Aug 17, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/22ql9d/market_analysis) has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering. The report analyzes the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies like Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company. The latest annual reports of all companies were analyzed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources. Key Topics Covered: 1. Pharmaceutical And Pharmaceutical Company 1.1 Pharmaceutical Company 1.2 Definition Of Medicinal Product Or Drug 1.3 Classification Of Drugs 1.4 History Of Drugs 1.5 Ancient Pharmacology 1.6 Medieval Pharmacology 1.7 Modern Pharmacology 1.8 Drugs And Intellectual Property Rights 2. Generic Industry 2.1 Generic Industry 2.2 Introduction To The Generic Market 2.3 Leading Companies In The Generic Industry 2.4 The Generic Industry And Mergers & Acquisitions 2.5 Generic Industry & Emerging Markets 2.6 Conclusion To The Generics Industry 3. Pharmaceutical Industries In Selected Countries Of The World 3.1 German Pharmaceutical Industry 3.2 Russian Pharmaceutical Market 3.3 Russian Pharma Company 3.4 Russian Pharmaceuticals Market 3.5 Us Pharmaceuticals Market 3.6 Australia Pharmaceuticals Industry 3.7 China Pharmaceuticals Industry 3.8 Indian Pharmaceuticals Industry 4. Financial Analysis Of Top Pharmaceutical Companies 4.1 Pfizer 4.2 Johnson & Johnson 4.3 Abbott Pharmaceuticals 4.4 Gilead 4.5 Sun Pharma 4.6 Glaxo Smith Kline Annual Report 4.7 Eli Lilly & Company Annual Report 5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation 5.1 Trends In The Pharmaceutical And Related Industries 5.2 Value Chains 5.3 Supply Chains 5.4 Process, Development & Design 5.5 Optimised Planning Of Tests 5.6 Capacity And Portfolio Planning Under Uncertainty 5.7 Combined Testing And Capacity Planning 5.8 Classical Supply Chain Planning And Management 5.9 Issues/Structure 5.10 Dynamic Supply Chain Analysis 5.11 A Particular Market 5.12 Comparison Of Two Supply Chain Responses 5.13 Some Conclusions 5.14 Future Perspectives 6. Management, Discussion And Analysis Report Of Global Pharma Industry 7. Summary For more information visit http://www.researchandmarkets.com/research/22...t_analysis
LLY: 73.64 (-0.22)
Pharmaceutical Directory of China 2015
M2 - Tue Jul 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wz73cd/pharmaceutical) has announced the addition of the "Pharmaceutical Directory of China 2015" directory to their offering. The Chinese pharmaceutical industry has increased with high annual average growth rates over the last few decades. And during 2014 this strong growth is expected to continue unabated. This new edition of the China Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to China's ever-changing pharmaceutical industry. If you need to source from, or sell to China, Pharmaceuticals, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you're looking to break into this appealing market, the new China Pharmaceutical Directory will provide you with thousands of fresh business contacts - and help you keep track of old ones - quickly and easily. This one directory covers the entire Chinese pharmaceutical & biotechnology industries sector. This Directory will enable you to: - Profile a market - Build new business prospects - Pinpoint key executives - Generate new customers - Discover who your competitors are - Make vital contacts - Save the time, money and effort of doing your own research - Identify alternative suppliers and manufacturers - Source up-to-date company information - Access a wealth of quality information on companies and key personnel. Look at the information you'll get in the China Pharmaceutical Directory: - Address - Telephone, fax numbers - Email, website - Names of senior management and board members - Senior executives - Description of business activities - Subsidiaries and associates - Number of employees For more information visit http://www.researchandmarkets.com/research/wz...maceutical
China Pharmaceuticals Markets Research And Forecast Report: Radiant Insights
M2 - Wed Jun 03, 11:42AM CDT
RadiantInsights.com has announced the addition of "China Pharmaceuticals Markets Trends, Growth And Forecast Report : Radiant Insights, Inc" Market Research Report to their Database.
China Pharmaceuticals Markets Growth, Trends
M2 - Tue Jun 02, 7:47AM CDT
China's demand for Pharmaceuticals (http://www.radiantinsights.com/research/pharmaceuticals-markets-in-china) has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.
China Pharmaceuticals and Healthcare Report Q1 2015
PR Newswire - Wed Dec 24, 7:30AM CST
BMI View:Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.
